HealthDay on MSN14d
FDA Approves More Broadly Protective Meningococcal Vaccine
The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for acti ...
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week
GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage recommendations on Feb. 26.
Healio15d
FDA approves GSK’s pentavalent meningococcal vaccine
The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 years against ...
Medscape10d
Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs
Such herd immunity effects have been demonstrated following the introduction of meningococcal serogroup C conjugate (MCC) vaccines, with reductions in disease attack rates in unimmunized ...
Neurology Advisor5d
Meningococcal Vaccination Recommended Before Switch to Ravulizumab in NMOSD
For patients transitioning from rituximab to ravulizumab, meningococcal vaccination can be safely done within 6 months after stopping rituximab.
Cavalier Daily1d
U.Va. student diagnosed with Meningococcal disease
Bonner said anyone exhibiting symptoms of the disease should make an appointment with Student Health and Wellness for ...
Monthly Prescribing Reference12d
Pentavalent Meningococcal Vaccine Penmenvy Gets FDA Approval
Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
HealthDay on MSN6d
Advisory Committee on Immunization Practices February Meeting Postponed
The latest meeting of the U.S. Centers for Disease Control and Prevention Advisory Committee on Immunization Practi ...
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week (UPDATED)
The story has been updated to correct the FDA approval date to Friday, February 14 On Friday, February 14, the FDA approved GSK plc’s (NYSE:GSK) Penmenvy (Meningococcal Groups A, B, C, W, and Y ...
clinicaladvisor.com11d
Pentavalent Meningococcal Vaccine Penmenvy Gets FDA Approval
The CDC’s Advisory Committee on Immunization Practices is expected to provide recommendations on the appropriate use of Penmenvy at its meeting on February 26, 2025. The Food and Drug ...